Role of Perivascular Adipose Tissue in Vascular Physiology and Pathology

Hypertension

Volumn 69, Issue 5, 2017, Pages 770-777

  Huang Cao, Zhen Fang ^a   Stoffel, Elina ^a   Cohen, Paul ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOSE TISSUE; AUTONOMIC NERVOUS SYSTEM; BLOOD VESSEL FUNCTION; BLOOD VESSEL REACTIVITY; HUMAN; NONHUMAN; PERIVASCULAR ADIPOSE TISSUE; PHENOTYPE; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; VASCULAR DISEASE; ANIMAL; BLOOD VESSEL; CORONARY ARTERY DISEASE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADIPOSE TISSUE; ANIMALS; BLOOD VESSELS; CORONARY ARTERY DISEASE; HUMANS;

EID: 85015795983     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.116.08451     Document Type: Review

References (103)

1. DeMarco VG, Aroor AR, Sowers JR, The pathophysiology of hypertension in patients with obesity. Nat Rev Endocrinol 2014 10 364-376. doi: 10.1038/nrendo.2014.44.
2. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ, Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003 42 1206-1252. doi: 10.1161/01.HYP.0000107251.49515.c2.
3. Lawes CM, Vander Hoorn S, Rodgers A, International Society of Hypertension Global burden of blood-pressure-related disease, 2001. Lancet 2008 371 1513-1518. doi: 10.1016/S0140-6736(08)60655-8.
4. Rao MV, Qiu Y, Wang C, Bakris G, Hypertension and CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES), 1999-2004. Am J Kidney Dis 2008 51 4 suppl 2 S30-S37. doi: 10.1053/j.ajkd.2007.12.012.
5. Narayan KM, Ali MK, Koplan JP, Global noncommunicable diseases-where worlds meet. N Engl J Med 2010 363 1196-1198. doi: 10.1056/NEJMp1002024.
6. Hamet P, Pausova Z, Adarichev V, Adaricheva K, Tremblay J, Hypertension: genes and environment. J Hypertens 1998 16 397-418
7. Kannel WB, Brand N, Skinner JJ Jr, Dawber TR, McNamara PM, The relation of adiposity to blood pressure and development of hypertension. The Framingham study. Ann Intern Med 1967 67 48-59
8. Kotsis V, Stabouli S, Bouldin M, Low A, Toumanidis S, Zakopoulos N, Impact of obesity on 24-hour ambulatory blood pressure and hypertension. Hypertension 2005 45 602-607. doi: 10.1161/01.HYP.0000158261.86674.8e.
9. Flegal KM, Kruszon-Moran D, Carroll MD, Fryar CD, Ogden CL, Trends in obesity among adults in the United States, 2005 to 2014. JAMA 2016 315 2284-2291. doi: 10.1001/jama.2016.6458.
10. Rosen ED, Spiegelman BM, What we talk about when we talk about fat. Cell 2014 156 20-44
11. Ouchi N, Parker JL, Lugus JJ, Walsh K, Adipokines in inflammation and metabolic disease. Nat Rev Immunol 2011 11 85-97. doi: 10.1038/nri2921.
12. Britton KA, Fox CS, Perivascular adipose tissue and vascular disease. Clin Lipidol 2011 6 79-91. doi: 10.2217/clp.10.89.
13. Hilzendeger AM, Morgan DA, Brooks L, Dellsperger D, Liu X, Grobe JL, Rahmouni K, Sigmund CD, Mark AL, A brain leptin-renin angiotensin system interaction in the regulation of sympathetic nerve activity. Am J Physiol Heart Circ Physiol 2012 303 H197-H206. doi: 10.1152/ajpheart.00974.2011.
14. Simonds SE, Pryor JT, Ravussin E, Leptin mediates the increase in blood pressure associated with obesity. Cell 2014 159 1404-1416. doi: 10.1016/j.cell.2014.10.058.
15. Hall JE, do Carmo JM, da Silva AA, Wang Z, Hall ME, Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms. Circ Res 2015 116 991-1006. doi: 10.1161/CIRCRESAHA.116.305697.
16. Fernández-Alfonso MS, Gil-Ortega M, García-Prieto CF, Aranguez I, Ruiz-Gayo M, Somoza B, Mechanisms of perivascular adipose tissue dysfunction in obesity. Int J Endocrinol 2013 2013 402053. doi: 10.1155/2013/402053.
17. Szasz T, Bomfim GF, Webb RC, The influence of perivascular adipose tissue on vascular homeostasis. Vasc Health Risk Manag 2013 9 105-116. doi: 10.2147/VHRM.S33760.
18. Gao YJ, Lu C, Su LY, Sharma AM, Lee RM, Modulation of vascular function by perivascular adipose tissue: the role of endothelium and hydrogen peroxide. Br J Pharmacol 2007 151 323-331. doi: 10.1038/sj.bjp.0707228.
19. Majesky MW, Adventitia and perivascular cells. Arterioscler Thromb Vasc Biol 2015 35 e31-e35. doi: 10.1161/ATVBAHA.115.306088.
20. Miao CY, Li ZY, The role of perivascular adipose tissue in vascular smooth muscle cell growth. Br J Pharmacol 2012 165 643-658. doi: 10.1111/j.1476-5381.2011.01404.x.
21. Gálvez-Prieto B, Dubrovska G, Cano MV, Delgado M, Aranguez I, González MC, Ruiz-Gayo M, Gollasch M, Fernández-Alfonso MS, A reduction in the amount and anti-contractile effect of periadventitial mesenteric adipose tissue precedes hypertension development in spontaneously hypertensive rats. Hypertens Res 2008 31 1415-1423. doi: 10.1291/hypres.31.1415.
22. Takaoka M, Nagata D, Kihara S, Shimomura I, Kimura Y, Tabata Y, Saito Y, Nagai R, Sata M, Periadventitial adipose tissue plays a critical role in vascular remodeling. Circ Res 2009 105 906-911. doi: 10.1161/CIRCRESAHA.109.199653.
23. Rittig K, Dolderer JH, Balletshofer B, Machann J, Schick F, Meile T, Küper M, Stock UA, Staiger H, Machicao F, Schaller HE, Königsrainer A, Häring HU, Siegel-Axel DI, The secretion pattern of perivascular fat cells is different from that of subcutaneous and visceral fat cells. Diabetologia 2012 55 1514-1525. doi: 10.1007/s00125-012-2481-9.
24. Omar A, Chatterjee TK, Tang Y, Hui DY, Weintraub NL, Proinflammatory phenotype of perivascular adipocytes. Arterioscler Thromb Vasc Biol 2014 34 1631-1636. doi: 10.1161/ATVBAHA.114.303030.
25. Gálvez-Prieto B, Bolbrinker J, Stucchi P, de Las Heras AI, Merino B, Arribas S, Ruiz-Gayo M, Huber M, Wehland M, Kreutz R, Fernandez-Alfonso MS, Comparative expression analysis of the renin-angiotensin system components between white and brown perivascular adipose tissue. J Endocrinol 2008 197 55-64. doi: 10.1677/JOE-07-0284.
26. Wang P, Xu TY, Guan YF, Su DF, Fan GR, Miao CY, Perivascular adipose tissue-derived visfatin is a vascular smooth muscle cell growth factor: role of nicotinamide mononucleotide. Cardiovasc Res 2009 81 370-380. doi: 10.1093/cvr/cvn288.
27. Fitzgibbons TP, Kogan S, Aouadi M, Hendricks GM, Straubhaar J, Czech MP, Similarity of mouse perivascular and brown adipose tissues and their resistance to diet-induced inflammation. Am J Physiol Heart Circ Physiol 2011 301 H1425-H1437. doi: 10.1152/ajpheart.00376.2011.
28. Padilla J, Jenkins NT, Vieira-Potter VJ, Laughlin MH, Divergent phenotype of rat thoracic and abdominal perivascular adipose tissues. Am J Physiol Regul Integr Comp Physiol 2013 304 R543-R552. doi: 10.1152/ajpregu.00567.2012.
29. Gao X, Belmadani S, Picchi A, Xu X, Potter BJ, Tewari-Singh N, Capobianco S, Chilian WM, Zhang C, Tumor necrosis factor-alpha induces endothelial dysfunction in Lepr(db) mice. Circulation 2007 115 245-254. doi: 10.1161/CIRCULATIONAHA.106.650671.
30. Sacks HS, Fain JN, Holman B, Cheema P, Chary A, Parks F, Karas J, Optican R, Bahouth SW, Garrett E, Wolf RY, Carter RA, Robbins T, Wolford D, Samaha J, Uncoupling protein-1 and related messenger ribonucleic acids in human epicardial and other adipose tissues: epicardial fat functioning as brown fat. J Clin Endocrinol Metab 2009 94 3611-3615. doi: 10.1210/jc.2009-0571.
31. Tchkonia T, Lenburg M, Thomou T, Identification of depot-specific human fat cell progenitors through distinct expression profiles and developmental gene patterns. Am J Physiol Endocrinol Metab 2007 292 E298-E307. doi: 10.1152/ajpendo.00202.2006.
32. Chatterjee TK, Stoll LL, Denning GM, Harrelson A, Blomkalns AL, Idelman G, Rothenberg FG, Neltner B, Romig-Martin SA, Dickson EW, Rudich S, Weintraub NL, Proinflammatory phenotype of perivascular adipocytes: influence of high-fat feeding. Circ Res 2009 104 541-549. doi: 10.1161/CIRCRESAHA.108.182998.
33. Chang L, Villacorta L, Li R, Hamblin M, Xu W, Dou C, Zhang J, Wu J, Zeng R, Chen YE, Loss of perivascular adipose tissue on peroxisome proliferator-activated receptor-γ deletion in smooth muscle cells impairs intravascular thermoregulation and enhances atherosclerosis. Circulation 2012 126 1067-1078. doi: 10.1161/CIRCULATIONAHA.112.104489.
34. Greenstein AS, Khavandi K, Withers SB, Sonoyama K, Clancy O, Jeziorska M, Laing I, Yates AP, Pemberton PW, Malik RA, Heagerty AM, Local inflammation and hypoxia abolish the protective anticontractile properties of perivascular fat in obese patients. Circulation 2009 119 1661-1670. doi: 10.1161/CIRCULATIONAHA.108.821181.
35. Ketonen J, Shi J, Martonen E, Mervaala E, Periadventitial adipose tissue promotes endothelial dysfunction via oxidative stress in diet-induced obese C57Bl/6 mice. Circ J 2010 74 1479-1487
36. Lehman SJ, Massaro JM, Schlett CL, O'Donnell CJ, Hoffmann U, Fox CS, Peri-aortic fat, cardiovascular disease risk factors, and aortic calcification: the Framingham Heart Study. Atherosclerosis 2010 210 656-661. doi: 10.1016/j.atherosclerosis.2010.01.007.
37. Marchesi C, Ebrahimian T, Angulo O, Paradis P, Schiffrin EL, Endothelial nitric oxide synthase uncoupling and perivascular adipose oxidative stress and inflammation contribute to vascular dysfunction in a rodent model of metabolic syndrome. Hypertension 2009 54 1384-1392. doi: 10.1161/HYPERTENSIONAHA.109.138305.
38. Fox CS, Massaro JM, Hoffmann U, Pou KM, Maurovich-Horvat P, Liu CY, Vasan RS, Murabito JM, Meigs JB, Cupples LA, D'Agostino RB Sr, O'Donnell CJ, Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 2007 116 39-48. doi: 10.1161/CIRCULATIONAHA.106.675355.
39. Vague J, The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease. Am J Clin Nutr 1956 4 20-34
40. Rosito GA, Massaro JM, Hoffmann U, Ruberg FL, Mahabadi AA, Vasan RS, O'Donnell CJ, Fox CS, Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: the Framingham Heart Study. Circulation 2008 117 605-613. doi: 10.1161/CIRCULATIONAHA.107.743062.
41. Lee RM, Ding L, Lu C, Su LY, Gao YJ, Alteration of perivascular adipose tissue function in angiotensin II-induced hypertension. Can J Physiol Pharmacol 2009 87 944-953. doi: 10.1139/y09-088.
42. Ruan CC, Zhu DL, Chen QZ, Chen J, Guo SJ, Li XD, Gao PJ, Perivascular adipose tissue-derived complement 3 is required for adventitial fibroblast functions and adventitial remodeling in deoxycorticosterone acetate-salt hypertensive rats. Arterioscler Thromb Vasc Biol 2010 30 2568-2574. doi: 10.1161/ATVBAHA.110.215525.
43. Soltis EE, Cassis LA, Influence of perivascular adipose tissue on rat aortic smooth muscle responsiveness. Clin Exp Hypertens A 1991 13 277-296
44. Löhn M, Dubrovska G, Lauterbach B, Luft FC, Gollasch M, Sharma AM, Periadventitial fat releases a vascular relaxing factor. FASEB J 2002 16 1057-1063. doi: 10.1096/fj.02-0024com.
45. Verlohren S, Dubrovska G, Tsang SY, Essin K, Luft FC, Huang Y, Gollasch M, Visceral periadventitial adipose tissue regulates arterial tone of mesenteric arteries. Hypertension 2004 44 271-276. doi: 10.1161/01.HYP.0000140058.28994.ec.
46. Lu C, Zhao AX, Gao YJ, Lee RM, Modulation of vein function by perivascular adipose tissue. Eur J Pharmacol 2011 657 111-116. doi: 10.1016/j.ejphar.2010.12.028.
47. Reifenberger MS, Turk JR, Newcomer SC, Booth FW, Laughlin MH, Perivascular fat alters reactivity of coronary artery: effects of diet and exercise. Med Sci Sports Exerc 2007 39 2125-2134. doi: 10.1249/mss.0b013e318156e9df.
48. Rittig K, Staib K, Machann J, Böttcher M, Peter A, Schick F, Claussen C, Stefan N, Fritsche A, Häring HU, Balletshofer B, Perivascular fatty tissue at the brachial artery is linked to insulin resistance but not to local endothelial dysfunction. Diabetologia 2008 51 2093-2099. doi: 10.1007/s00125-008-1128-3.
49. Dubrovska G, Verlohren S, Luft FC, Gollasch M, Mechanisms of ADRF release from rat aortic adventitial adipose tissue. Am J Physiol Heart Circ Physiol 2004 286 H1107-H1113. doi: 10.1152/ajpheart.00656.2003.
50. Gao YJ, Holloway AC, Zeng ZH, Lim GE, Petrik JJ, Foster WG, Lee RM, Prenatal exposure to nicotine causes postnatal obesity and altered perivascular adipose tissue function. Obes Res 2005 13 687-692. doi: 10.1038/oby.2005.77.
51. Gao YJ, Takemori K, Su LY, An WS, Lu C, Sharma AM, Lee RM, Perivascular adipose tissue promotes vasoconstriction: the role of superoxide anion. Cardiovasc Res 2006 71 363-373. doi: 10.1016/j.cardiores.2006.03.013.
52. Meyer MR, Fredette NC, Barton M, Prossnitz ER, Regulation of vascular smooth muscle tone by adipose-derived contracting factor. PLoS One 2013 8 e79245. doi: 10.1371/journal.pone.0079245.
53. Owen MK, Witzmann FA, McKenney ML, Lai X, Berwick ZC, Moberly SP, Alloosh M, Sturek M, Tune JD, Perivascular adipose tissue potentiates contraction of coronary vascular smooth muscle: influence of obesity. Circulation 2013 128 9-18. doi: 10.1161/CIRCULATIONAHA.112.001238.
54. Watts SW, Dorrance AM, Penfold ME, Rourke JL, Sinal CJ, Seitz B, Sullivan TJ, Charvat TT, Thompson JM, Burnett R, Fink GD, Chemerin connects fat to arterial contraction. Arterioscler Thromb Vasc Biol 2013 33 1320-1328. doi: 10.1161/ATVBAHA.113.301476.
55. Brown NK, Zhou Z, Zhang J, Zeng R, Wu J, Eitzman DT, Chen YE, Chang L, Perivascular adipose tissue in vascular function and disease: a review of current research and animal models. Arterioscler Thromb Vasc Biol 2014 34 1621-1630. doi: 10.1161/ATVBAHA.114.303029.
56. Zaborska KE, Wareing M, Edwards G, Austin C, Loss of anti-contractile effect of perivascular adipose tissue in offspring of obese rats. Int J Obes 2016 40 1205-1214. doi: 10.1038/ijo.2016.62.
57. Drake AJ, Reynolds RM, Impact of maternal obesity on offspring obesity and cardiometabolic disease risk. Reproduction 2010 140 387-398. doi: 10.1530/REP-10-0077.
58. Fraser A, Tilling K, Macdonald-Wallis C, Sattar N, Brion MJ, Benfield L, Ness A, Deanfield J, Hingorani A, Nelson SM, Smith GD, Lawlor DA, Association of maternal weight gain in pregnancy with offspring obesity and metabolic and vascular traits in childhood. Circulation 2010 121 2557-2564. doi: 10.1161/CIRCULATIONAHA.109.906081.
59. Samuelsson AM, Matthews PA, Argenton M, Christie MR, McConnell JM, Jansen EH, Piersma AH, Ozanne SE, Twinn DF, Remacle C, Rowlerson A, Poston L, Taylor PD, Diet-induced obesity in female mice leads to offspring hyperphagia, adiposity, hypertension, and insulin resistance: a novel murine model of developmental programming. Hypertension 2008 51 383-392. doi: 10.1161/HYPERTENSIONAHA.107.101477.
60. Fortuño A, Rodríguez A, Gómez-Ambrosi J, Frühbeck G, Díez J, Adipose tissue as an endocrine organ: role of leptin and adiponectin in the pathogenesis of cardiovascular diseases. J Physiol Biochem 2003 59 51-60
61. Vlasova M, Purhonen AK, Jarvelin MR, Rodilla E, Pascual J, Herzig KH, Role of adipokines in obesity-associated hypertension. Acta Physiol 2010 200 107-127. doi: 10.1111/j.1748-1716.2010.02171.x.
62. Cao R, Brakenhielm E, Wahlestedt C, Thyberg J, Cao Y, Leptin induces vascular permeability and synergistically stimulates angiogenesis with FGF-2 and VEGF. Proc Natl Acad Sci USA 2001 98 6390-6395. doi: 10.1073/pnas.101564798.
63. Carlyle M, Jones OB, Kuo JJ, Hall JE, Chronic cardiovascular and renal actions of leptin: role of adrenergic activity. Hypertension 2002 39 2 pt 2 496-501
64. Cheng KK, Lam KS, Wang Y, Huang Y, Carling D, Wu D, Wong C, Xu A, Adiponectin-induced endothelial nitric oxide synthase activation and nitric oxide production are mediated by APPL1 in endothelial cells. Diabetes 2007 56 1387-1394. doi: 10.2337/db06-1580.
65. Wong WT, Tian XY, Xu A, Yu J, Lau CW, Hoo RL, Wang Y, Lee VW, Lam KS, Vanhoutte PM, Huang Y, Adiponectin is required for PPARγ-mediated improvement of endothelial function in diabetic mice. Cell Metab 2011 14 104-115. doi: 10.1016/j.cmet.2011.05.009.
66. Fésüs G, Dubrovska G, Gorzelniak K, Kluge R, Huang Y, Luft FC, Gollasch M, Adiponectin is a novel humoral vasodilator. Cardiovasc Res 2007 75 719-727. doi: 10.1016/j.cardiores.2007.05.025.
67. Hirai H, Satoh H, Kudoh A, Watanabe T, Interaction between resistin and adiponectin in the proliferation of rat vascular smooth muscle cells. Mol Cell Endocrinol 2013 366 108-116. doi: 10.1016/j.mce.2012.12.009.
68. Rabe K, Lehrke M, Parhofer KG, Broedl UC, Adipokines and insulin resistance. Mol Med 2008 14 741-751. doi: 10.2119/2008-00058.Rabe.
69. Verma S, Li SH, Wang CH, Fedak PW, Li RK, Weisel RD, Mickle DA, Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction. Circulation 2003 108 736-740. doi: 10.1161/01.CIR.0000084503.91330.49.
70. Ruan H, Miles PD, Ladd CM, Ross K, Golub TR, Olefsky JM, Lodish HF, Profiling gene transcription in vivo reveals adipose tissue as an immediate target of tumor necrosis factor-alpha: implications for insulin resistance. Diabetes 2002 51 3176-3188
71. Greenberg S, Xie J, Wang Y, Cai B, Kolls J, Nelson S, Hyman A, Summer WR, Lippton H, Tumor necrosis factor-alpha inhibits endothelium-dependent relaxation. J Appl Physiol 1993 74 2394-2403
72. Picchi A, Gao X, Belmadani S, Potter BJ, Focardi M, Chilian WM, Zhang C, Tumor necrosis factor-alpha induces endothelial dysfunction in the prediabetic metabolic syndrome. Circ Res 2006 99 69-77. doi: 10.1161/01.RES.0000229685.37402.80.
73. Chen X, Andresen BT, Hill M, Zhang J, Booth F, Zhang C, Role of reactive oxygen species in tumor necrosis factor-alpha induced endothelial dysfunction. Curr Hypertens Rev 2008 4 245-255
74. Klouche M, Bhakdi S, Hemmes M, Rose-John S, Novel path to activation of vascular smooth muscle cells: up-regulation of gp130 creates an autocrine activation loop by IL-6 and its soluble receptor. J Immunol 1999 163 4583-4589
75. Neves KB, Lobato NS, Lopes RA, Filgueira FP, Zanotto CZ, Oliveira AM, Tostes RC, Chemerin reduces vascular nitric oxide/cGMP signalling in rat aorta: a link to vascular dysfunction in obesity? Clin Sci 2014 127 111-122. doi: 10.1042/CS20130286.
76. Hart R, Greaves DR, Chemerin contributes to inflammation by promoting macrophage adhesion to VCAM-1 and fibronectin through clustering of VLA-4 and VLA-5. J Immunol 2010 185 3728-3739. doi: 10.4049/jimmunol.0902154.
77. Neves KB, Nguyen Dinh Cat A, Lopes RA, Rios FJ, Anagnostopoulou A, Lobato NS, de Oliveira AM, Tostes RC, Montezano AC, Touyz RM, Chemerin regulates crosstalk between adipocytes and vascular cells through Nox. Hypertension 2015 66 657-666. doi: 10.1161/HYPERTENSIONAHA.115.05616.
78. Gabay C, Interleukin-6 and chronic inflammation. Arthritis Res Ther 2006 8 suppl 2 S3. doi: 10.1186/ar1917.
79. Deshmane SL, Kremlev S, Amini S, Sawaya BE, Monocyte chemoattractant protein-1 (MCP-1): an overview. J Interferon Cytokine Res 2009 29 313-326. doi: 10.1089/jir.2008.0027.
80. Verhagen SN, Visseren FL, Perivascular adipose tissue as a cause of atherosclerosis. Atherosclerosis 2011 214 3 10. doi: 10.1016/j.atherosclerosis.2010.05.034.
81. Chen Y, Budd RC, Kelm RJ Jr, Sobel BE, Schneider DJ, Augmentation of proliferation of vascular smooth muscle cells by plasminogen activator inhibitor type 1. Arterioscler Thromb Vasc Biol 2006 26 1777-1783. doi: 10.1161/01.ATV.0000227514.50065.2a.
82. Cines DB, Pollak ES, Buck CA, Loscalzo J, Zimmerman GA, McEver RP, Pober JS, Wick TM, Konkle BA, Schwartz BS, Barnathan ES, McCrae KR, Hug BA, Schmidt AM, Stern DM, Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 1998 91 3527-3561
83. Quyyumi AA, Dakak N, Mulcahy D, Andrews NP, Husain S, Panza JA, Cannon RO III, Nitric oxide activity in the atherosclerotic human coronary circulation. J Am Coll Cardiol 1997 29 308-317
84. Wójcicka G, Jamroz-Wiśniewska A, Atanasova P, Chaldakov GN, Chylińska-Kula B, Bełtowski J, Differential effects of statins on endogenous H2S formation in perivascular adipose tissue. Pharmacol Res 2011 63 68-76. doi: 10.1016/j.phrs.2010.10.011.
85. Lu C, Su LY, Lee RM, Gao YJ, Mechanisms for perivascular adipose tissue-mediated potentiation of vascular contraction to perivascular neuronal stimulation: the role of adipocyte-derived angiotensin II. Eur J Pharmacol 2010 634 107-112. doi: 10.1016/j.ejphar.2010.02.006.
86. Lee RM, Lu C, Su LY, Gao YJ, Endothelium-dependent relaxation factor released by perivascular adipose tissue. J Hypertens 2009 27 782-790. doi: 10.1097/HJH.0b013e328324ed86.
87. Borda ES, Sterin-Borda L, Gimeno MF, Lazzari MA, Gimeno AL, The stimulatory effect of prostacyclin (PGI2) on isolated rabbit and rat aorta is probably associated to the generation of a thromboxane A2 (TXA2) "like-material". Arch Int Pharmacodyn Ther 1983 261 79-89
88. Chang L, Milton H, Eitzman DT, Chen YE, Paradoxical roles of perivascular adipose tissue in atherosclerosis and hypertension. Circ J 2013 77 11-18
89. Lee YC, Chang HH, Chiang CL, Liu CH, Yeh JI, Chen MF, Chen PY, Kuo JS, Lee TJ, Role of perivascular adipose tissue-derived methyl palmitate in vascular tone regulation and pathogenesis of hypertension. Circulation 2011 124 1160-1171. doi: 10.1161/CIRCULATIONAHA.111.027375.
90. Lamers D, Schlich R, Greulich S, Sasson S, Sell H, Eckel J, Oleic acid and adipokines synergize in inducing proliferation and inflammatory signalling in human vascular smooth muscle cells. J Cell Mol Med 2011 15 1177-1188. doi: 10.1111/j.1582-4934.2010.01099.x.
91. Ruan CC, Ma Y, Ge Q, Li Y, Zhu LM, Zhang Y, Kong LR, Wu QW, Li F, Cheng L, Zhao AZ, Zhu DL, Gao PJ, Complement-mediated inhibition of adiponectin regulates perivascular inflammation and vascular injury in hypertension [published online ahead of print December 14, 2016]. FASEB J. doi: 10.1096/fj.201600780R.
92. Chen Y, Wang X, Mai J, Zhao X, Liang Y, Gu M, Chen Z, Nie R, Wang J, C-reactive protein promotes vascular endothelial dysfunction partly via activating adipose tissue inflammation in hyperlipidemic rabbits. Int J Cardiol 2013 168 2397-2403. doi: 10.1016/j.ijcard.2013.01.158.
93. Du B, Ouyang A, Eng JS, Fleenor BS, Aortic perivascular adipose-derived interleukin-6 contributes to arterial stiffness in low-density lipoprotein receptor deficient mice. Am J Physiol Heart Circ Physiol 2015 308 H1382-H1390. doi: 10.1152/ajpheart.00712.2014.
94. Roh SG, Song SH, Choi KC, Katoh K, Wittamer V, Parmentier M, Sasaki S, Chemerin-a new adipokine that modulates adipogenesis via its own receptor. Biochem Biophys Res Commun 2007 362 1013-1018. doi: 10.1016/j.bbrc.2007.08.104.
95. Ernst MC, Haidl ID, Zúñiga LA, Dranse HJ, Rourke JL, Zabel BA, Butcher EC, Sinal CJ, Disruption of the chemokine-like receptor-1 (CMKLR1) gene is associated with reduced adiposity and glucose intolerance. Endocrinology 2012 153 672-682. doi: 10.1210/en.2011-1490.
96. Lehrke M, Becker A, Greif M, Stark R, Laubender RP, von Ziegler F, Lebherz C, Tittus J, Reiser M, Becker C, Göke B, Leber AW, Parhofer KG, Broedl UC, Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis. Eur J Endocrinol 2009 161 339-344. doi: 10.1530/EJE-09-0380.
97. Weigert J, Neumeier M, Wanninger J, Filarsky M, Bauer S, Wiest R, Farkas S, Scherer MN, Schäffler A, Aslanidis C, Schölmerich J, Buechler C, Systemic chemerin is related to inflammation rather than obesity in type 2 diabetes. Clin Endocrinol 2010 72 342-348. doi: 10.1111/j.1365-2265.2009.03664.x.
98. Darios ES, Winner BM, Charvat T, Krasinksi A, Punna S, Watts SW, The adipokine chemerin amplifies electrical field-stimulated contraction in the isolated rat superior mesenteric artery. Am J Physiol Heart Circ Physiol 2016 311 H498-H507. doi: 10.1152/ajpheart.00998.2015.
99. Cannon B, Nedergaard J, Lundberg JM, Hökfelt T, Terenius L, Goldstein M, 'Neuropeptide tyrosine' (NPY) is co-stored with noradrenaline in vascular but not in parenchymal sympathetic nerves of brown adipose tissue. Exp Cell Res 1986 164 546-550
100. Cinti S, The adipose organ at a glance. Dis Model Mech 2012 5 588-594. doi: 10.1242/dmm.009662.
101. Corry DB, Tuck ML, Obesity, hypertension, and sympathetic nervous system activity. Curr Hypertens Rep 1999 1 119-126
102. Ayala-Lopez N, Martini M, Jackson WF, Darios E, Burnett R, Seitz B, Fink GD, Watts SW, Perivascular adipose tissue contains functional catecholamines. Pharmacol Res Perspect 2014 2 e00041. doi: 10.1002/prp2.41.
103. Ayala-Lopez N, Jackson WF, Burnett R, Wilson JN, Thompson JM, Watts SW, Organic cation transporter 3 contributes to norepinephrine uptake into perivascular adipose tissue. Am J Physiol Heart Circ Physiol 2015 309 H1904-H1914. doi: 10.1152/ajpheart.00308.2015.